Despite More Prescriptions, Naloxone is Still Dramatically Underprescribed. When given promptly, naloxone can reverse an opioid overdose and save a life. But despite an increase in prescriptions since 2012, and despite being recommended as a risk mitigation strategy in the CDC Guideline for Prescribing Opioids for Chronic Pain, naloxone is still highly underprescribed, according to a new study from the Centers for Disease Control and Prevention.
Medication-based treatment with methadone, buprenorphine, or extended-release naltrexone is effective for opioid use disorder (OUD), saving lives and improving long-term outcomes even in the absence of other forms of treatment, according to a major new review from the National Academies of Sciences, Engineering, and Medicine. The study was led by Alan Leshner, Emeritus CEO of the American Association for the Advancement of Science, the publisher of the journal Science.